Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Bryan Haugen

Concepts (503)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
95
2025
309
16.750
 Why?
Iodine Radioisotopes
29
2025
142
3.890
 Why?
Thyroid Nodule
18
2025
55
3.800
 Why?
Adenocarcinoma, Follicular
19
2024
34
3.730
 Why?
Carcinoma, Papillary
24
2017
76
3.570
 Why?
Thyroid Gland
26
2018
94
3.420
 Why?
Endocrinology
10
2020
74
3.160
 Why?
Thyrotropin
30
2023
109
2.820
 Why?
Carcinoma
10
2025
215
1.880
 Why?
Thyroid Diseases
8
2020
35
1.510
 Why?
Thyroidectomy
17
2024
86
1.440
 Why?
Antineoplastic Agents
15
2022
2041
1.320
 Why?
Retinoid X Receptors
11
2011
40
1.310
 Why?
Retinoids
7
2011
33
1.230
 Why?
Hypothyroidism
8
2023
70
1.210
 Why?
Tetrahydronaphthalenes
6
2015
29
1.200
 Why?
Thyroid Carcinoma, Anaplastic
6
2019
35
1.190
 Why?
Biomarkers, Tumor
15
2024
1175
1.100
 Why?
Thyroxine
12
2023
62
1.100
 Why?
Receptors, Retinoic Acid
7
2004
51
1.040
 Why?
Biopsy, Fine-Needle
9
2021
66
0.980
 Why?
NF-kappa B
3
2015
649
0.970
 Why?
Lymphatic Metastasis
7
2024
317
0.930
 Why?
Ultrasonography
8
2025
708
0.920
 Why?
Carcinoma, Papillary, Follicular
4
2014
8
0.910
 Why?
Neoplasm Proteins
6
2013
419
0.860
 Why?
Transcription Factors
15
2014
1628
0.860
 Why?
Gene Expression Profiling
6
2020
1681
0.840
 Why?
Thyroglobulin
8
2024
26
0.830
 Why?
Cell Line, Tumor
19
2020
3168
0.820
 Why?
Humans
135
2025
128019
0.800
 Why?
Radiopharmaceuticals
3
2012
166
0.790
 Why?
Struma Ovarii
2
2014
7
0.790
 Why?
Proto-Oncogene Proteins B-raf
3
2023
212
0.720
 Why?
Neoplasm Invasiveness
6
2017
477
0.700
 Why?
Thiazolidinediones
4
2018
137
0.700
 Why?
Promoter Regions, Genetic
14
2018
1198
0.700
 Why?
Pituitary Gland
6
2011
148
0.690
 Why?
History, 20th Century
7
2018
285
0.680
 Why?
Oncogene Proteins, Fusion
2
2019
198
0.670
 Why?
Lymph Nodes
5
2018
465
0.650
 Why?
Cell Differentiation
5
2020
1896
0.630
 Why?
Neoplasm Recurrence, Local
8
2024
955
0.610
 Why?
T-Lymphocytes, Regulatory
3
2015
366
0.610
 Why?
Triiodothyronine
4
2017
44
0.600
 Why?
Neoplasm Metastasis
10
2015
608
0.600
 Why?
History, 21st Century
6
2018
177
0.590
 Why?
Hypothalamus
2
2011
144
0.580
 Why?
Proto-Oncogene Proteins p21(ras)
1
2019
258
0.570
 Why?
Societies, Medical
6
2020
741
0.550
 Why?
Recombinant Proteins
9
2009
1286
0.550
 Why?
Mutation
11
2023
3682
0.550
 Why?
Programmed Cell Death 1 Receptor
3
2016
226
0.550
 Why?
Neoplasm Staging
14
2021
1288
0.530
 Why?
Ovarian Neoplasms
2
2014
487
0.530
 Why?
Multimodal Imaging
2
2014
109
0.520
 Why?
Molecular Targeted Therapy
3
2015
384
0.520
 Why?
Pharmacogenomic Testing
1
2016
60
0.510
 Why?
Drug Resistance, Neoplasm
3
2016
744
0.500
 Why?
Transcriptome
3
2020
879
0.500
 Why?
DNA-Binding Proteins
13
2014
1421
0.500
 Why?
Terminology as Topic
1
2017
199
0.490
 Why?
Protein-Tyrosine Kinases
1
2019
430
0.490
 Why?
Thyroid Hormones
4
2020
54
0.480
 Why?
Databases, Genetic
1
2016
228
0.480
 Why?
Famous Persons
1
2014
7
0.470
 Why?
Tomography, Emission-Computed, Single-Photon
2
2014
76
0.460
 Why?
Anticarcinogenic Agents
1
2015
77
0.460
 Why?
Immunotherapy, Adoptive
1
2017
295
0.450
 Why?
Physician Executives
1
2014
33
0.450
 Why?
Data Collection
3
2016
645
0.450
 Why?
Reverse Transcriptase Polymerase Chain Reaction
9
2014
940
0.450
 Why?
Mice
28
2022
16574
0.450
 Why?
Gene Expression Regulation, Neoplastic
7
2018
1343
0.440
 Why?
Hyperthyroidism
2
2012
28
0.440
 Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1558
0.440
 Why?
Genes, Tumor Suppressor
1
2014
86
0.440
 Why?
Neoplasm Transplantation
5
2019
257
0.440
 Why?
Gene Expression
2
2012
1454
0.430
 Why?
Combined Modality Therapy
8
2021
1199
0.430
 Why?
Medical Oncology
1
2016
271
0.420
 Why?
Interleukin-8
1
2014
258
0.410
 Why?
Middle Aged
36
2024
30812
0.410
 Why?
Phenylurea Compounds
2
2024
89
0.400
 Why?
Research
1
2016
408
0.400
 Why?
Proteomics
3
2010
1008
0.400
 Why?
RNA, Messenger
15
2012
2669
0.400
 Why?
Neovascularization, Pathologic
1
2014
289
0.390
 Why?
Quinolines
2
2024
154
0.390
 Why?
Pituitary Gland, Anterior
4
2002
39
0.380
 Why?
Female
52
2024
68016
0.380
 Why?
Radiotherapy, Adjuvant
2
2012
209
0.380
 Why?
Cell Proliferation
9
2019
2337
0.380
 Why?
Animals
32
2022
34487
0.370
 Why?
Decision Support Techniques
1
2015
396
0.370
 Why?
Practice Guidelines as Topic
5
2020
1482
0.360
 Why?
Bone Neoplasms
2
2012
229
0.360
 Why?
Protein Kinase Inhibitors
3
2024
875
0.360
 Why?
Telomerase
5
2019
231
0.350
 Why?
Prognosis
12
2024
3766
0.350
 Why?
DNA, Neoplasm
2
2008
159
0.350
 Why?
Aged
25
2024
21892
0.350
 Why?
Male
46
2024
62757
0.350
 Why?
Blotting, Western
8
2014
1169
0.340
 Why?
PPAR gamma
3
2009
182
0.340
 Why?
Carrier Proteins
1
2014
730
0.330
 Why?
T-Lymphocytes
2
2017
1921
0.330
 Why?
MAP Kinase Kinase 2
1
2009
29
0.320
 Why?
Cell Culture Techniques
2
2009
344
0.320
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2009
12
0.320
 Why?
MAP Kinase Kinase 1
1
2009
76
0.320
 Why?
Forkhead Transcription Factors
1
2010
181
0.320
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2009
34
0.310
 Why?
Treatment Outcome
18
2024
10110
0.300
 Why?
Iodide Peroxidase
2
2005
28
0.300
 Why?
Adult
34
2024
35176
0.290
 Why?
Hormone Replacement Therapy
2
2020
89
0.290
 Why?
Benzodioxoles
1
2009
105
0.290
 Why?
Receptors, Cytoplasmic and Nuclear
2
2009
215
0.280
 Why?
Quinazolines
1
2009
243
0.280
 Why?
Signal Transduction
5
2016
4812
0.280
 Why?
MAP Kinase Signaling System
1
2009
304
0.280
 Why?
Cell Transformation, Neoplastic
2
2012
324
0.280
 Why?
Adenoma
3
2025
212
0.280
 Why?
Retrospective Studies
12
2025
14404
0.270
 Why?
S100 Proteins
1
2006
36
0.260
 Why?
Disease-Free Survival
5
2021
647
0.260
 Why?
Adenoma, Oxyphilic
2
2024
6
0.260
 Why?
Diagnosis, Differential
6
2025
1408
0.260
 Why?
Lipoprotein Lipase
2
2004
58
0.260
 Why?
Apoptosis
4
2012
2425
0.250
 Why?
Tomography, X-Ray Computed
3
2018
2509
0.250
 Why?
Evidence-Based Medicine
3
2020
709
0.250
 Why?
Neoplasms
3
2016
2460
0.250
 Why?
Molecular Diagnostic Techniques
2
2021
97
0.250
 Why?
Mice, Nude
5
2018
675
0.240
 Why?
Oligonucleotide Array Sequence Analysis
3
2014
755
0.240
 Why?
Melanoma
2
2009
722
0.240
 Why?
Tumor Cells, Cultured
8
2009
930
0.240
 Why?
Goiter, Nodular
1
2004
2
0.230
 Why?
Retinoid X Receptor gamma
1
2004
4
0.230
 Why?
Sensitivity and Specificity
6
2024
1813
0.230
 Why?
Chromosomal Proteins, Non-Histone
2
2002
115
0.230
 Why?
Galectin 3
1
2004
20
0.230
 Why?
Dietary Fats
2
2004
301
0.230
 Why?
United States
13
2023
13785
0.220
 Why?
Immunohistochemistry
7
2020
1663
0.220
 Why?
Microtubule-Associated Proteins
2
2002
189
0.220
 Why?
Radionuclide Imaging
4
2010
121
0.220
 Why?
Molecular Sequence Data
13
2006
2820
0.210
 Why?
Drug Resistance
2
2022
165
0.210
 Why?
Cell Line
4
2022
2736
0.210
 Why?
Whole-Body Counting
2
2006
6
0.210
 Why?
Prospective Studies
12
2023
7035
0.210
 Why?
Aged, 80 and over
10
2024
7029
0.200
 Why?
Tamoxifen
2
2020
200
0.200
 Why?
Cell Cycle Proteins
1
2006
578
0.200
 Why?
Disease Models, Animal
4
2022
3936
0.200
 Why?
Benzoates
3
2009
41
0.200
 Why?
Reoperation
1
2024
541
0.190
 Why?
Cytodiagnosis
1
2021
32
0.190
 Why?
Xenograft Model Antitumor Assays
4
2020
809
0.180
 Why?
Lymphoma
1
2002
194
0.180
 Why?
Polymorphism, Single Nucleotide
1
2008
2059
0.180
 Why?
Thyroid Hormone Resistance Syndrome
1
2000
1
0.180
 Why?
Base Sequence
11
2002
2134
0.170
 Why?
Consensus
3
2020
607
0.170
 Why?
Carcinoma, Neuroendocrine
1
2020
32
0.170
 Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
3
2010
136
0.170
 Why?
CD8-Positive T-Lymphocytes
3
2016
840
0.170
 Why?
Adenocarcinoma
3
2017
888
0.170
 Why?
Antibodies, Monoclonal, Humanized
1
2024
754
0.160
 Why?
Vascular Endothelial Growth Factor A
1
2022
499
0.160
 Why?
Nitriles
2
2010
159
0.160
 Why?
Transfection
5
2005
891
0.150
 Why?
Thyrotropin, beta Subunit
2
2011
5
0.140
 Why?
Receptors, Estrogen
1
2020
424
0.140
 Why?
Workflow
1
2018
154
0.140
 Why?
Algorithms
5
2018
1609
0.140
 Why?
Antigens, Neoplasm
1
2020
308
0.140
 Why?
Up-Regulation
1
2020
822
0.140
 Why?
Neck
2
2015
92
0.140
 Why?
Intercellular Adhesion Molecule-1
1
2017
133
0.140
 Why?
Tissue Extracts
1
2017
19
0.140
 Why?
Heterografts
2
2015
128
0.140
 Why?
Disease Progression
6
2020
2598
0.140
 Why?
Transcription Factor Pit-1
8
1999
24
0.130
 Why?
Muscle, Skeletal
2
2004
1619
0.130
 Why?
Enzyme Inhibitors
2
2010
809
0.130
 Why?
Parathyroidectomy
1
2016
7
0.130
 Why?
Tretinoin
1
1997
127
0.130
 Why?
Colorado
3
2014
4369
0.130
 Why?
Homeodomain Proteins
3
1999
489
0.130
 Why?
Ligands
3
2009
616
0.130
 Why?
Caspase 7
1
2015
20
0.120
 Why?
Diet
1
2023
1198
0.120
 Why?
Information Storage and Retrieval
1
2016
108
0.120
 Why?
Prolactin
2
1999
99
0.120
 Why?
Larynx
1
2016
55
0.120
 Why?
Bortezomib
1
2015
45
0.120
 Why?
Hypocalcemia
1
2015
28
0.120
 Why?
User-Computer Interface
1
2016
147
0.120
 Why?
Inhibitory Concentration 50
1
2015
82
0.120
 Why?
Radiation, Ionizing
1
2015
76
0.120
 Why?
Taxoids
1
2015
95
0.120
 Why?
Risk Assessment
4
2024
3223
0.120
 Why?
Transcriptional Activation
2
1994
355
0.120
 Why?
Double-Blind Method
2
2012
1852
0.120
 Why?
Laryngoscopy
1
2016
99
0.120
 Why?
Pharmacogenetics
1
2016
171
0.120
 Why?
Tumor Suppressor Protein p53
1
2019
504
0.120
 Why?
Immunotherapy
2
2016
586
0.120
 Why?
Immunophenotyping
2
2015
309
0.120
 Why?
Guidelines as Topic
1
2016
260
0.110
 Why?
Energy Metabolism
1
2000
831
0.110
 Why?
Societies, Scientific
1
2014
45
0.110
 Why?
Caspase 3
1
2015
229
0.110
 Why?
Growth Hormone
1
1994
96
0.110
 Why?
NF-KappaB Inhibitor alpha
1
2014
48
0.110
 Why?
Predictive Value of Tests
2
2019
1934
0.110
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
251
0.110
 Why?
DNA Mutational Analysis
2
2020
384
0.110
 Why?
Histiocytoma, Benign Fibrous
1
1994
8
0.110
 Why?
Lymphocytes, Tumor-Infiltrating
1
2016
210
0.110
 Why?
Diagnostic Techniques, Endocrine
1
2013
14
0.110
 Why?
Graves Disease
2
2012
35
0.110
 Why?
ROC Curve
1
2015
500
0.110
 Why?
I-kappa B Proteins
1
2014
73
0.110
 Why?
Cell Death
1
2015
342
0.110
 Why?
Preoperative Care
3
2024
335
0.110
 Why?
Transduction, Genetic
1
2014
128
0.110
 Why?
Young Adult
6
2024
12281
0.110
 Why?
Stilbenes
1
2013
36
0.110
 Why?
Human Umbilical Vein Endothelial Cells
1
2014
97
0.110
 Why?
Registries
6
2015
1873
0.110
 Why?
Drug Resistance, Multiple
1
2013
22
0.110
 Why?
Transcription, Genetic
5
2011
1403
0.100
 Why?
Sirolimus
1
2014
189
0.100
 Why?
Genetic Variation
1
2018
933
0.100
 Why?
Observer Variation
1
2013
310
0.100
 Why?
Nuclear Proteins
1
1997
657
0.100
 Why?
Contraindications
1
2012
87
0.100
 Why?
T-Lymphocyte Subsets
2
2015
409
0.100
 Why?
Thiazoles
1
2012
115
0.090
 Why?
Receptors, Thyroid Hormone
3
1996
21
0.090
 Why?
src-Family Kinases
1
2012
95
0.090
 Why?
Protein Isoforms
2
2004
377
0.090
 Why?
Thyroiditis, Autoimmune
2
2020
15
0.090
 Why?
Glycoprotein Hormones, alpha Subunit
1
2011
22
0.090
 Why?
Genomics
1
2016
714
0.090
 Why?
TOR Serine-Threonine Kinases
1
2014
380
0.090
 Why?
Adolescent
7
2024
20158
0.090
 Why?
Mice, 129 Strain
1
2011
79
0.090
 Why?
Polymerase Chain Reaction
4
2005
1020
0.090
 Why?
Oleanolic Acid
1
2010
8
0.090
 Why?
Quality Improvement
1
2018
1093
0.090
 Why?
Cells, Cultured
3
2014
4006
0.090
 Why?
Pilot Projects
1
2015
1559
0.090
 Why?
Whole Body Imaging
1
2010
20
0.090
 Why?
Amino Acid Sequence
4
2006
2042
0.080
 Why?
Weight Gain
2
2023
503
0.080
 Why?
Ribonucleases
3
2002
54
0.080
 Why?
Electrophoresis, Gel, Two-Dimensional
2
2008
97
0.080
 Why?
Somatostatin
1
2009
55
0.080
 Why?
Endometrial Neoplasms
2
2002
164
0.080
 Why?
Diphosphonates
1
2010
56
0.080
 Why?
Antibody Specificity
1
2010
182
0.080
 Why?
Lymphocyte Subsets
1
2010
85
0.080
 Why?
Dopamine Agonists
1
2009
39
0.080
 Why?
Lymphoma, T-Cell
1
2009
22
0.080
 Why?
Breast Neoplasms
2
2020
2131
0.080
 Why?
Sulfones
1
2010
108
0.080
 Why?
Butadienes
1
2009
35
0.080
 Why?
Bone Density Conservation Agents
1
2010
71
0.080
 Why?
Hysterectomy
1
2010
118
0.080
 Why?
Calcium
1
2015
1182
0.080
 Why?
Postoperative Complications
2
2023
2456
0.080
 Why?
Radiotherapy
1
2010
185
0.080
 Why?
Time Factors
3
2010
6479
0.080
 Why?
Drug Screening Assays, Antitumor
1
2009
195
0.080
 Why?
Pyrimidines
1
2012
446
0.080
 Why?
Benzamides
1
2009
195
0.080
 Why?
Membrane Proteins
1
2015
1105
0.080
 Why?
Drug Evaluation, Preclinical
1
2009
168
0.080
 Why?
Phosphorylation
2
2012
1681
0.070
 Why?
Flow Cytometry
1
2012
1140
0.070
 Why?
CD4-Positive T-Lymphocytes
2
2015
1043
0.070
 Why?
Lymphocyte Activation
1
2012
1096
0.070
 Why?
Cohort Studies
5
2023
5378
0.070
 Why?
Proportional Hazards Models
3
2023
1194
0.070
 Why?
Enzyme Activation
1
2009
796
0.070
 Why?
Autoantibodies
2
2013
1461
0.070
 Why?
Phenotype
3
2015
3039
0.070
 Why?
Follow-Up Studies
5
2024
4853
0.070
 Why?
S100 Calcium Binding Protein A6
1
2006
1
0.070
 Why?
RNA, Small Interfering
1
2009
569
0.070
 Why?
Reproducibility of Results
2
2019
3009
0.070
 Why?
Pituitary Neoplasms
2
1999
183
0.060
 Why?
Colonic Neoplasms
1
2008
242
0.060
 Why?
Drug Delivery Systems
1
2009
327
0.060
 Why?
Metformin
1
2009
312
0.060
 Why?
Fatty Acids, Nonesterified
1
2006
159
0.060
 Why?
Postoperative Care
2
2018
235
0.060
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2006
115
0.060
 Why?
Neoplasm Grading
2
2018
283
0.060
 Why?
Chromatin Immunoprecipitation
1
2005
131
0.060
 Why?
Brain Neoplasms
1
2014
1163
0.060
 Why?
Inhibitor of Apoptosis Proteins
2
2002
45
0.060
 Why?
Glucocorticoids
1
2009
572
0.060
 Why?
RNA, Neoplasm
2
2002
87
0.060
 Why?
Blotting, Southern
2
1996
68
0.060
 Why?
Paclitaxel
1
2006
213
0.060
 Why?
Neck Dissection
1
2024
15
0.060
 Why?
Recurrent Laryngeal Nerve Injuries
1
2024
12
0.060
 Why?
Chromosome Mapping
2
1997
504
0.060
 Why?
Adjuvants, Pharmaceutic
1
2004
10
0.060
 Why?
Tomography, Emission-Computed
1
2004
66
0.060
 Why?
Organic Chemicals
1
2005
128
0.060
 Why?
DNA, Mitochondrial
1
2005
188
0.060
 Why?
Luciferases
1
2004
147
0.060
 Why?
Immunoprecipitation
1
2004
157
0.060
 Why?
Triglycerides
1
2006
523
0.060
 Why?
Quality of Life
3
2022
2672
0.060
 Why?
Heart Neoplasms
2
2015
49
0.060
 Why?
Probability
2
2021
304
0.050
 Why?
Cell Cycle Checkpoints
2
2016
95
0.050
 Why?
Dose-Response Relationship, Drug
2
2005
1943
0.050
 Why?
Lymph Node Excision
1
2024
164
0.050
 Why?
Professional Practice
1
2003
63
0.050
 Why?
Computers
1
2023
65
0.050
 Why?
National Institutes of Health (U.S.)
1
2023
122
0.050
 Why?
Protein Binding
1
2009
2105
0.050
 Why?
Genetic Testing
2
2018
428
0.050
 Why?
Poly A
1
2002
48
0.050
 Why?
5' Untranslated Regions
1
2002
55
0.050
 Why?
Gene Library
1
2002
115
0.050
 Why?
Magnetic Resonance Imaging
2
2010
3371
0.050
 Why?
Cell Division
1
2004
777
0.050
 Why?
DNA, Complementary
1
2002
266
0.050
 Why?
Point Mutation
1
2002
221
0.050
 Why?
Endometrium
1
2002
61
0.050
 Why?
Child
1
2021
20636
0.050
 Why?
Survival Analysis
3
2010
1262
0.050
 Why?
Thallium
1
2001
1
0.050
 Why?
Thallium Radioisotopes
1
2001
8
0.050
 Why?
Organotechnetium Compounds
1
2001
10
0.050
 Why?
Carcinoma, Endometrioid
1
2002
47
0.050
 Why?
Biopsy, Needle
1
2002
187
0.050
 Why?
Plasmids
1
2002
354
0.050
 Why?
Patient Care Management
1
2001
56
0.050
 Why?
Life Style
1
2023
459
0.040
 Why?
Thyroid Function Tests
2
2017
14
0.040
 Why?
Cell Cycle
1
2004
580
0.040
 Why?
Macrophages
2
2020
1460
0.040
 Why?
Health Status
1
2006
747
0.040
 Why?
MutS Homolog 2 Protein
1
2020
13
0.040
 Why?
MCF-7 Cells
1
2020
115
0.040
 Why?
Mice, Transgenic
1
2005
2066
0.040
 Why?
Specialization
1
2001
144
0.040
 Why?
Calcitonin
1
2020
27
0.040
 Why?
Models, Animal
1
2022
365
0.040
 Why?
Pituitary Hormones
1
1999
16
0.040
 Why?
Receptors, Virus
1
2020
83
0.040
 Why?
Mice, SCID
1
2020
350
0.040
 Why?
Risk Factors
3
2023
9696
0.040
 Why?
Medicine
1
2001
117
0.040
 Why?
Antineoplastic Agents, Hormonal
1
2020
158
0.040
 Why?
Validation Studies as Topic
1
2019
21
0.040
 Why?
Singapore
1
2019
20
0.040
 Why?
Cost-Benefit Analysis
1
2022
567
0.040
 Why?
Octreotide
1
1999
27
0.040
 Why?
Lymphoma, T-Cell, Cutaneous
1
1999
43
0.040
 Why?
Drug Therapy, Combination
1
2022
1012
0.040
 Why?
Immune System
1
2020
176
0.040
 Why?
Mice, Inbred NOD
1
2020
586
0.040
 Why?
Leukocytes
1
2020
303
0.040
 Why?
Surveys and Questionnaires
3
2020
5353
0.040
 Why?
Luminescence
1
2018
35
0.040
 Why?
Kaplan-Meier Estimate
1
2020
851
0.040
 Why?
Radiation Tolerance
1
1999
97
0.040
 Why?
Pharmacogenomic Variants
1
2018
35
0.040
 Why?
DNA Mismatch Repair
1
2018
47
0.040
 Why?
North America
1
2018
289
0.040
 Why?
Age Factors
3
2015
3100
0.040
 Why?
Interdisciplinary Communication
1
2018
185
0.040
 Why?
Dietary Carbohydrates
1
1998
150
0.040
 Why?
Oncogenes
1
2018
109
0.040
 Why?
Delphi Technique
1
2018
221
0.030
 Why?
Liver
1
2005
1826
0.030
 Why?
Doxorubicin
1
1999
322
0.030
 Why?
Soft Tissue Neoplasms
1
2018
112
0.030
 Why?
Gene Frequency
1
2018
504
0.030
 Why?
Health Policy
1
2020
351
0.030
 Why?
Advisory Committees
1
2018
214
0.030
 Why?
Tissue Distribution
1
1997
295
0.030
 Why?
DNA
4
1996
1392
0.030
 Why?
Adverse Drug Reaction Reporting Systems
1
2017
73
0.030
 Why?
Stroboscopy
1
2016
5
0.030
 Why?
DNA Fingerprinting
1
1996
25
0.030
 Why?
Deoxyribonuclease I
1
1996
38
0.030
 Why?
Immunomodulation
1
2016
90
0.030
 Why?
RNA
1
2002
881
0.030
 Why?
Surgeons
1
2020
259
0.030
 Why?
Tumor Suppressor Proteins
1
2018
313
0.030
 Why?
Antithyroid Agents
2
2006
13
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2019
484
0.030
 Why?
Clinical Trials as Topic
1
2020
997
0.030
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2015
29
0.030
 Why?
Chromosomes, Human, Pair 4
1
1995
28
0.030
 Why?
Mutagenesis, Site-Directed
1
1996
358
0.030
 Why?
Lymphocyte Count
1
2015
150
0.030
 Why?
Mutagenesis, Insertional
1
1994
65
0.030
 Why?
Cytotoxicity, Immunologic
1
2015
216
0.030
 Why?
Adipose Tissue
1
1998
589
0.030
 Why?
Microsatellite Repeats
1
2014
161
0.030
 Why?
Mice, Knockout
1
2020
2757
0.030
 Why?
Gene Expression Regulation
4
1997
2508
0.030
 Why?
Age of Onset
1
2015
490
0.030
 Why?
Proto-Oncogene Proteins c-bcl-2
1
1995
228
0.030
 Why?
Risk
2
2006
850
0.030
 Why?
Head and Neck Neoplasms
1
2018
532
0.030
 Why?
Computational Biology
1
2018
595
0.030
 Why?
Genes, Neoplasm
1
2013
20
0.030
 Why?
Killer Cells, Natural
1
2016
426
0.030
 Why?
Preoperative Period
1
2013
113
0.030
 Why?
Gene Deletion
1
1994
369
0.030
 Why?
Neutropenia
1
2013
134
0.030
 Why?
Case-Control Studies
2
2015
3324
0.030
 Why?
Alternative Splicing
1
1994
216
0.030
 Why?
DNA, Single-Stranded
1
1993
114
0.020
 Why?
Postoperative Period
1
2013
322
0.020
 Why?
Focal Adhesion Kinase 1
1
2012
29
0.020
 Why?
Reference Values
2
2005
776
0.020
 Why?
Dasatinib
1
2012
51
0.020
 Why?
Genetic Markers
1
2013
338
0.020
 Why?
Recurrence
1
2015
993
0.020
 Why?
Autophagy
1
2014
265
0.020
 Why?
Repressor Proteins
1
1995
399
0.020
 Why?
Saccharomyces cerevisiae Proteins
1
1995
377
0.020
 Why?
Age Distribution
1
2012
369
0.020
 Why?
Sex Distribution
1
2012
356
0.020
 Why?
Tumor Burden
1
2012
283
0.020
 Why?
Primary Health Care
1
2001
1639
0.020
 Why?
Longevity
1
2012
149
0.020
 Why?
Universities
1
2013
399
0.020
 Why?
Interleukin-6
1
2014
712
0.020
 Why?
Obesity
1
2023
2859
0.020
 Why?
Protein Processing, Post-Translational
1
2012
451
0.020
 Why?
Menopause
1
2012
291
0.020
 Why?
Cell Survival
1
2012
1073
0.020
 Why?
Cross-Sectional Studies
1
2020
5034
0.020
 Why?
Early Detection of Cancer
1
2013
369
0.020
 Why?
Physical Examination
1
2009
230
0.020
 Why?
Calreticulin
1
2008
27
0.020
 Why?
Binding Sites
3
1996
1241
0.020
 Why?
Exons
2
2002
338
0.020
 Why?
Insulin
1
1998
2316
0.020
 Why?
Drug Administration Schedule
1
2009
755
0.020
 Why?
Cytokines
1
2015
1984
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor Proteins
1
2006
7
0.020
 Why?
Chromans
1
2006
23
0.020
 Why?
Radiotherapy Dosage
1
2006
250
0.020
 Why?
International Cooperation
1
2006
171
0.020
 Why?
Feasibility Studies
1
2009
860
0.020
 Why?
Angiogenesis Inhibitors
1
2006
215
0.010
 Why?
Radiography
1
2006
794
0.010
 Why?
Inflammation
1
2014
2646
0.010
 Why?
Peptides
1
2008
910
0.010
 Why?
Neoplasm, Residual
1
2003
119
0.010
 Why?
Biopsy
1
2006
1077
0.010
 Why?
Culture Techniques
1
2002
80
0.010
 Why?
Models, Biological
1
2008
1689
0.010
 Why?
Fushi Tarazu Transcription Factors
1
1999
5
0.010
 Why?
Steroidogenic Factor 1
1
1999
6
0.010
 Why?
Pain
1
2006
748
0.010
 Why?
Gonadotropins
1
1999
37
0.010
 Why?
Postmenopause
1
2002
348
0.010
 Why?
Analysis of Variance
1
2002
1266
0.010
 Why?
Carcinoma, Medullary
1
1998
14
0.010
 Why?
DNA Primers
1
1999
509
0.010
 Why?
Follicle Stimulating Hormone
1
1999
235
0.010
 Why?
Organ Specificity
1
1998
290
0.010
 Why?
GATA2 Transcription Factor
1
1997
14
0.010
 Why?
Logistic Models
1
2002
1975
0.010
 Why?
Sequence Deletion
1
1996
178
0.010
 Why?
3T3 Cells
1
1995
151
0.010
 Why?
Muridae
1
1995
5
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
1995
111
0.010
 Why?
Replication Protein C
1
1995
4
0.010
 Why?
Macromolecular Substances
1
1995
211
0.010
 Why?
Hybrid Cells
1
1995
50
0.010
 Why?
Mutagenesis
1
1995
181
0.010
 Why?
Minor Histocompatibility Antigens
1
1995
46
0.010
 Why?
Mice, Inbred DBA
1
1994
186
0.010
 Why?
Body Weight
1
1998
930
0.010
 Why?
Survival Rate
1
1998
1870
0.010
 Why?
Cloning, Molecular
1
1994
522
0.010
 Why?
Blotting, Northern
1
1993
198
0.010
 Why?
Haplotypes
1
1995
471
0.010
 Why?
Sex Factors
1
1998
1942
0.010
 Why?
Protein Biosynthesis
1
1993
397
0.010
 Why?
Rats
1
1996
5199
0.000
 Why?
Mice, Inbred C57BL
1
1995
5268
0.000
 Why?
Haugen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (503) concept(s)
_
Co-Authors Expand Description
See all (44) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)